Paintbrush dripping orange paint onto glossy droplets under a microscope

Who we are

About Paint

Paint Therapeutics is a biotechnology company developing peptide-drug conjugates that improve how inhaled medicines deposit in lung tissue and stay there.

Company Overview

Our lead platform, PulmoPaint, is focused on pulmonary disease, starting with pulmonary arterial hypertension.

Leadership

Meet the Team

  • Portrait of Bill Reddick

    Bill Reddick

    Co-founder & CEO

  • Portrait of Ron Sarkar, PhD, MBA

    Ron SarkarPhD, MBA

    BD

  • Portrait of John Thomas, PhD

    John ThomasPhD

    Analytical Development and CMC

  • Portrait of Dani Stoltzfus, PhD

    Dani StoltzfusPhD

    R&D

  • Portrait of Mariah Stewart, PhD

    Mariah StewartPhD

    Scientific Program Advisor

Work with us

Let's build medicines that deliver.

Get in Touch